Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 22:S0003-4967(25)04416-4.
doi: 10.1016/j.ard.2025.09.012. Online ahead of print.

Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome

Elpida Phithak  1 , Fredrik N Albach  1 , Ioanna Minopoulou  1 , Robert Biesen  1 , Arnd Kleyer  2 , Edgar Wiebe  1 , Elise Siegert  1 , Veronika Scholz  1 , Marie Rehm  1 , Qingyu Cheng  3 , Arne Sattler  2 , Stefano Bianco  1 , Anja Fleischmann  1 , Kay-Geert Hermann  4 , Thula Walter-Rittel  4 , Moritz Wagner  4 , Jan Zernicke  1 , Vincent Casteleyn  1 , Martin Nielsen  5 , Thomas Rose  1 , Antonia Busse  6 , Marie Luise Hütter-Krönke  7 , Ulrich Keller  6 , Udo Schneider  8 , Leona Kawelke  9 , Nikolas Ruffer  10 , Werner Stenzel  9 , Gerhard Krönke  11 , David Simon  12 , Tobias Alexander  2
Affiliations

Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome

Elpida Phithak et al. Ann Rheum Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests IM received speaker honoraria from AbbVie and Novartis. DS has served on scientific advisory boards for AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen-Cilag, Lilly, Novartis, and UCB; and received speaker honoraria from AbbVie, Alfasigma, Bristol-Myers Squibb, Janssen-Cilag, Lilly, Novartis, and UCB. AK has served on scientific advisory boards for AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen-Cilag, Lilly, Novartis, and UCB; and received speaker honoraria from AbbVie, Alfasigma, Bristol-Myers Squibb, Janssen-Cilag, Lilly, Novartis, and UCB.

LinkOut - more resources